Activin and follistatin in rat mammary gland

被引:7
作者
Bussmann, UA
Lanuza, GM
Bussmann, LE
机构
[1] Consejo Nacl Invest Cient & Tecn, IByME, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina
关键词
pregnancy; lactogenesis; growth differentiation; growth factors;
D O I
10.1016/j.mce.2004.04.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mammary gland morphogenesis and differentiation are mediated through the combined activities of systemic hormones and locally synthesized growth factors. Activin, a member of the transforming growth factor (TGF)-beta superfamily, is known to regulate the growth and differentiation of several cell types. In the present study, we investigated the role of activin in rat mammary gland on different stages of development. We found that activin A in vitro inhibits the proliferation of isolated acini, and this effect increases with the development of the gland. This factor also produces in vitro an inhibition of the final differentiation of acini obtained from 19th day pregnant rats. We also report the expression of activin receptors IIA and IIB mRNA in whole rat mammary gland and acini, with decreased levels of expression of type IIA (in both compartments) and IIB (in acini) during pregnancy and lactogenesis. In addition, we show that activin betaB-subunit mRNA decreases throughout pregnancy, and that the mRNA levels of follistatin (Fst) (its ligand protein) are high in cycling rats and at the beginning of pregnancy and diminish thereafter, having the acini higher levels of expression. Our data show that activin betaB-subunit, follistatin and ActRIIA and IIB transcripts are expressed in rat mammary gland at appropriate times and locations during development, allowing an interplay that might regulate activin action on growth and differentiation of the gland. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:9 / 19
页数:11
相关论文
共 47 条
[1]   Activins as regulators of branching morphogenesis [J].
Ball, EMA ;
Risbridger, GP .
DEVELOPMENTAL BIOLOGY, 2001, 238 (01) :1-12
[2]   Roles of the matrix metalloproteinases in mammary gland development and cancer [J].
Benaud, C ;
Dickson, RB ;
Thompson, EW .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 50 (02) :97-116
[3]   Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells [J].
Bondestam, J ;
Kaivo-oja, N ;
Kallio, J ;
Groome, N ;
Hydén-Granskog, C ;
Fujii, M ;
Moustakas, A ;
Jalanko, A ;
ten Dijke, P ;
Ritvos, O .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 195 (1-2) :79-88
[4]   HYBRIDIZATION HISTOCHEMICAL-LOCALIZATION OF ACTIVIN RECEPTOR SUBTYPES IN RAT-BRAIN, PITUITARY, OVARY, AND TESTIS [J].
CAMERON, VA ;
NISHIMURA, E ;
MATHEWS, LS ;
LEWIS, KA ;
SAWCHENKO, PE ;
VALE, WW .
ENDOCRINOLOGY, 1994, 134 (02) :799-808
[5]   Activin is a local regulator of human cytotrophoblast cell differentiation [J].
Caniggia, I ;
Lye, SJ ;
Cross, JC .
ENDOCRINOLOGY, 1997, 138 (09) :3976-3986
[6]   Activin a-induced HepG2 liver cell apoptosis: Involvement of activin receptors and Smad proteins [J].
Chen, W ;
Woodruff, TK ;
Mayo, KE .
ENDOCRINOLOGY, 2000, 141 (03) :1263-1272
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   The Role of TGF-β in Patterning and Growth of the Mammary Ductal Tree [J].
Daniel, Charles W. ;
Robinson, Stephen ;
Silberstein, Gary B. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1996, 1 (04) :331-341
[9]   Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): Regulation by cell surface follistatin [J].
Delbaere, A ;
Sidis, Y ;
Schneyer, AL .
ENDOCRINOLOGY, 1999, 140 (06) :2463-2470
[10]   Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors [J].
deWinter, JP ;
tenDijke, P ;
deVries, CJM ;
vanAchterberg, TAE ;
Sugino, H ;
deWaele, P ;
Huylebroeck, D ;
Verschueren, K ;
vandenEijndenvanRaaij, AJM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 116 (01) :105-114